Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pert

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Journal of Medicinal Chemistry|April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligandsB R de Costa, R B Rothman, V Bykov, et al.
FEBS Letters|June 5, 1989
Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptorB R de Costa, L Band, R B Rothman, et al.
NIDA Research Monograph|January 1, 1991
Preliminary evidence that the high affinity dopamine reuptake inhibitor, GBR12909, antagonizes the ability of cocaine to elevate extracellular levels of dopamineR B Rothman, A Mele, A A Reid, et al.
Peptides|September 1, 1984
Evidence for an endogenous peptide ligand for the phencyclidine receptorR Quirion, D A DiMaggio, E D French, et al.
Journal of Medicinal Chemistry|February 28, 1997
Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitorsD Matecka, D Lewis, R B Rothman, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1991
GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamineR B Rothman, A Mele, A A Reid, et al.
Peptides|January 1, 1981
Release of alpha-melanocyte stimulating hormone into rat and human cerebrospinal fluid in vivo and from rat hypothalamus slices in vitroT L O'Donohue, C G Charlton, N B Thoa, et al.
Synapse (New York, N.Y.)|May 1, 1993
Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transportersR B Rothman, B Lewis, C Dersch, et al.
Synapse (New York, N.Y.)|January 1, 1994
RTI-4793-14, a new ligand with high affinity and selectivity for the (+)-MK801-insensitive [3H]1-]1-(2-thienyl)cyclohexyl]piperidine binding site (PCP site 2) of guinea pig brainC B Goodman, D N Thomas, A Pert, et al.
Journal of Medicinal Chemistry|November 22, 1996
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)D Matecka, R B Rothman, L Radesca, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of Medicinal Chemistry|April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligandsB R de Costa, R B Rothman, V Bykov, et al.
FEBS Letters|June 5, 1989
Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptorB R de Costa, L Band, R B Rothman, et al.
NIDA Research Monograph|January 1, 1991
Preliminary evidence that the high affinity dopamine reuptake inhibitor, GBR12909, antagonizes the ability of cocaine to elevate extracellular levels of dopamineR B Rothman, A Mele, A A Reid, et al.
Peptides|September 1, 1984
Evidence for an endogenous peptide ligand for the phencyclidine receptorR Quirion, D A DiMaggio, E D French, et al.
Journal of Medicinal Chemistry|February 28, 1997
Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitorsD Matecka, D Lewis, R B Rothman, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1991
GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamineR B Rothman, A Mele, A A Reid, et al.
Peptides|January 1, 1981
Release of alpha-melanocyte stimulating hormone into rat and human cerebrospinal fluid in vivo and from rat hypothalamus slices in vitroT L O'Donohue, C G Charlton, N B Thoa, et al.
Synapse (New York, N.Y.)|May 1, 1993
Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transportersR B Rothman, B Lewis, C Dersch, et al.
Synapse (New York, N.Y.)|January 1, 1994
RTI-4793-14, a new ligand with high affinity and selectivity for the (+)-MK801-insensitive [3H]1-]1-(2-thienyl)cyclohexyl]piperidine binding site (PCP site 2) of guinea pig brainC B Goodman, D N Thomas, A Pert, et al.
Journal of Medicinal Chemistry|November 22, 1996
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)D Matecka, R B Rothman, L Radesca, et al.
Pageof 12